Test Price
2,800 AED✅ Home Collection Available
UAE MINISTRY OF HEALTH & PREVENTION (MOHAP) COMPLIANT REPORT | DHA LICENSE: 9834453
GRIN1 Gene Sequencing Test in UAE | 2800 AED | 2026 DHA Neurogenetic Guidelines
تحليل تسلسل جين GRIN1 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary | ملخص تنفيذي
- Executive Summary: This comprehensive genetic test screens the GRIN1 gene for autosomal dominant mental retardation type 8, utilizing Next-Generation Sequencing (NGS) technology for definitive molecular diagnosis. يقدم هذا الفحص الجيني الشامل تحليلًا لتسلسل جين GRIN1 المسؤول عن الإعاقة الذهنية الصبغية الجسدية السائدة من النوع 8 باستخدام تقنية متطورة.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity achieved via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy available 8 AM to 11 PM.
- Clinical Guidance: Mandatory pre-test genetic counselling included. Telephonic Post-Test Clinical Guidance provided by DHA-licensed molecular pathologists to aid result interpretation.
- Insurance: Direct Billing Verification available via WhatsApp at +971 54 548 8731.
1. Clinical Overview & Diagnostic Superiority
The GRIN1 gene test screens for pathogenic variants causing severe neurodevelopmental disorders, including autosomal dominant mental retardation type 8 (MRD8), characterized by intellectual disability, epilepsy, and movement disorders. يكشف هذا الاختبار الطفرات الجينية المسببة لاضطرابات النمو العصبي الحادة، بما في ذلك الإعاقة الذهنية من النوع 8 والصرع. Unlike outdated single-gene Sanger screening, our comprehensive NGS panel offers full coding region coverage and splice site analysis, detecting copy number variations (CNVs) otherwise missed by inferior methodologies.
| Diagnostic Metrics | Our NGS Protocol (UAE) | Closest Alternative (Standard Exome) |
|---|---|---|
| Analytical Sensitivity | >99.9% (Single Nucleotide & Indels) | ~95% (Variant Calling Dependent) |
| CNV Detection | Included (High-Depth Depth-of-Coverage Algorithm) | Absent (Requires adjunctive MLPA) |
| Reporting Turnaround | 3 to 4 Weeks (DHA-Compliant Urgency) | 8 to 12 Weeks |
2. Physician Insight & Safety Protocol
Clinical Correlative Note from Dr. PRABHAKAR REDDY (DHA: 61713011): "A positive GRIN1 variant confirms a molecular diagnosis, providing closure to a diagnostic odyssey and guiding prognosis regarding refractory epilepsy and cortical visual impairment. A negative result, however, necessitates a broader whole-genome evaluation to identify polygenic or mitochondrial contributions to the phenotype. This test is not a standalone diagnostic indicator of intelligence quotient."
⚠️ Safety Exclusion Criteria & Emergency Red Flags
Medication Warning: Do not discontinue prescribed antiepileptic, neuroleptic, or psychiatric medications before sample collection without explicit consultation with your managing consultant.
- Sample Integrity: Test requires high-molecular-weight DNA. Prior allogeneic bone marrow transplantation or recent blood transfusion (within 2 weeks) may result in false non-maternal/patient genotyping.
- ER Red Flags: Proceed to emergency department immediately if the patient develops status epilepticus (seizure lasting more than 5 minutes), severe aspiration pneumonia, or acute dystonic reaction, irrespective of pending genetic results.
- Pre-Analytical: Strictly adhere to the pre-test genetic counselling protocol (Pedigree chart mandatory per UAE CDS Law 2026 for minors).
3. Patient FAQ & Clinical Guidance
How accurate is NGS for detecting GRIN1-related mental retardation type 8 compared to older methods?
NGS offers >99.9% analytical sensitivity for single nucleotide variants and copy number variations, vastly outperforming Sanger sequencing by detecting deep intronic and mosaic mutations comprehensively. يوفر تسلسل الجيل التالي حساسية تفوق 99.9% لاكتشاف الطفرات مقارنة بالطرق القديمة.
What exactly is required for the pre-test genetic counselling session under UAE law?
The mandatory pre-test session requires a DHA-licensed counsellor to draw a three-generation pedigree chart and obtain informed consent specifically compliant with Federal Decree-Law No. 41 of 2024 (Art. 87) for genetic analysis. جلسة الاستشارة الوراثية إلزامية وتتضمن رسم شجرة العائلة والحصول على موافقة مستنيرة وفق القانون الاتحادي.
Can a negative GRIN1 test guarantee that my child does not have a neurological disorder?
A negative GRIN1 definitively rules out autosomal dominant MRD8 but cannot exclude other neurogenetic conditions, requiring further advanced testing like Whole Genome Sequencing for comprehensive diagnosis. النتيجة السلبية تستبعد الطفرة المحددة ولكنها لا تنفي وجود اضطرابات جينية عصبية أخرى.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians